Clinic
Healthcare Partners of Saratoga LTD
Healthcare Partners of Saratoga LTD was paid $8.86M by Medicaid between Jan 2018 and Nov 2024, across 120 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoHEALTHCARE PARTNERS OF SARATOGA LTD
MALTA, NY 12020
MALTA, NY 12020
33aNPI1700159613assigned 02/23/2012
33bProvider typeUrgent Care Clinic/Center
28Total paid$8.86M
24GClaims186,964
24DCodes billed120
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in New York
Rank by total paid#14 of 138
Median peer was paid$576K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FOSTER, GARY controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 98 | $15K | |
| 2019 | 8,302 | $566K | |
| 2020 | 20,477 | $1.14M | |
| 2021 | 38,422 | $1.77M | |
| 2022 | 39,472 | $1.86M | |
| 2023 | 44,840 | $1.97M | |
| 2024incomplete | 35,353 | $1.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 13,999 | 13,462 | $2.70M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 14,157 | 13,500 | $2.68M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 6,332 | 6,314 | $1.19M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 10.0% | 4,751 | 4,733 | $885K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.5% | 1,638 | 1,579 | $311K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.5% | 2,687 | 2,616 | $225K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.1% | 1,040 | 1,038 | $190K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 7,859 | 7,637 | $111K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 525 | 515 | $95K |
| 93975 | <1% | 611 | 603 | $56K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,849 | 1,838 | $53K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 976 | 954 | $44K |
108 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 654 | $40K |
| 80053 | Comprehensive metabolic panel | <1% | 11,148 | $32K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 8,633 | $18K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,569 | $15K |
| 99051 | <1% | 5,406 | $12K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 8,997 | $12K |
| 93971 | <1% | 539 | $12K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 967 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,079 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,528 | $10K |
| 12001 | <1% | 66 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,661 | $8K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 454 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,606 | $8K |
| 99053 | <1% | 2,841 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 751 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 242 | $7K |
| 80061 | Lipid panel | <1% | 1,110 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,223 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 236 | $6K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 112 | $6K |
| 84439 | <1% | 767 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,234 | $5K |
| 99205 | Prolong outpt/office vis | <1% | 30 | $5K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 12 | $5K |
| 76830 | Ultrasound, transvaginal | <1% | 363 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,739 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,986 | $3K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 109 | $3K |
| 76770 | <1% | 55 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 38 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,801 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,063 | $2K |
| 83735 | <1% | 1,511 | $1K | |
| 82728 | <1% | 112 | $1K | |
| 81001 | <1% | 5,272 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 359 | $1K |
| 76857 | <1% | 119 | $1K | |
| 73630 | <1% | 860 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 358 | $1K |
| 86618 | <1% | 319 | $938.55 | |
| 36416 | <1% | 109 | $928.87 | |
| 86140 | <1% | 305 | $784.27 | |
| 76775 | <1% | 28 | $709.22 | |
| 81025 | <1% | 3,876 | $699.03 | |
| 76536 | <1% | 26 | $696.91 | |
| 90715 | <1% | 54 | $619.28 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 17 | $597.93 |
| 70486 | <1% | 12 | $570.58 | |
| 83690 | <1% | 2,639 | $554.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,267 | $502.93 |
| 83540 | <1% | 108 | $461.68 | |
| 81003 | <1% | 2,833 | $455.64 | |
| 73610 | <1% | 646 | $450.38 | |
| 85652 | <1% | 367 | $429.98 | |
| 73130 | <1% | 457 | $393.82 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 84 | $369.61 |
| 83550 | <1% | 80 | $338.84 | |
| 84702 | <1% | 402 | $324.52 | |
| 87468 | <1% | 112 | $315.38 | |
| 73030 | <1% | 88 | $304.96 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 84 | $283.51 |
| 87484 | <1% | 112 | $276.72 | |
| 82607 | <1% | 24 | $268.25 | |
| 87088 | <1% | 1,863 | $265.24 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,365 | $247.10 |
| 74018 | <1% | 41 | $210.52 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 100 | $196.44 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,281 | $180.71 |
| 73564 | <1% | 52 | $174.73 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 89 | $174.03 |
| 84484 | <1% | 1,990 | $163.48 | |
| 86308 | <1% | 485 | $113.13 | |
| 85027 | <1% | 36 | $108.80 | |
| 85379 | <1% | 336 | $101.37 | |
| 73110 | <1% | 205 | $97.50 | |
| 87420 | <1% | 472 | $94.32 | |
| 87469 | <1% | 71 | $81.96 | |
| 73562 | <1% | 12 | $54.09 | |
| 87077 | <1% | 287 | $48.97 | |
| 72110 | <1% | 27 | $48.18 | |
| 85610 | <1% | 26 | $39.34 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 256 | $39.26 |
| 87070 | <1% | 352 | $24.53 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,619 | $19.97 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,796 | $19.17 |
| 83605 | <1% | 99 | $18.60 | |
| 87186 | <1% | 142 | $13.18 | |
| 82947 | <1% | 53 | $11.79 | |
| 71045 | Radiologic examination, chest; single view | <1% | 37 | $10.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 364 | $9.24 |
| 73140 | <1% | 25 | $7.50 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 839 | $5.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 563 | $4.33 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 408 | $2.00 |
| 87040 | 0% | 13 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 42 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 141 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 14 | $0.00 |
| 82962 | 0% | 47 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 13 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 50 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 14 | $0.00 |
| 99001 | 0% | 134 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 82 | $0.00 |
| 93041 | 0% | 12 | $0.00 | |
| 87905 | 0% | 14 | $0.00 | |
| 87899 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFOSTER, GARY (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Saratoga Hospital | Saratoga Springs, NY | $182K |
| Saratoga Hospital | Saratoga Springs, NY | $73K |
| Saratoga Hospital | Saratoga Springs, NY | $55K |
| Saratoga Hospital | Ballston Spa, NY | $42K |
| Saratoga Hospital | Saratoga Springs, NY | $15K |
| Saratoga Hospital | Saratoga Springs, NY | $10K |
| Saratoga Hospital | Mechanicville, NY | $9K |
| Saratoga Hospital | Saratoga Springs, NY | $6K |
| Saratoga Hospital | Saratoga Springs, NY | $5K |
| Saratoga Hospital | Schuylerville, NY | $2K |
| Saratoga Hospital | Galway, NY | $2K |
| Saratoga Hospital | Ballston Lake, NY | $1K |
| Saratoga Hospital | Gansevoort, NY | $577.80 |
| Saratoga Hospital | Malta, NY | $413.76 |
| Saratoga Hospital | Saratoga Springs, NY | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.